Background: Colorectal cancer is a common cause of death in developed countries. Progression from adenoma to invasive carcinoma requires accumulation of mutations starting with the Adenomatous Polyposis Coli (Apc) gene. NF-kB signalling is a key element in cancer, mainly related to the activity of IKKb. IKKa kinase also participates in this process by mechanisms that are primarily unknown.
Colorectal cancer (CRC) is the second leading cause of cancerrelated death in Western populations. Indeed, around half of the population will develop at least one benign tumour during their lifetime (Jemal et al, 2011) .
Several studies revealed a series of molecular events that are critical for the progression from colon adenoma to invasive carcinoma (Fearon and Vogelstein, 1990; Fearon, 2011) . One of the earliest events is the inactivating mutation in the Adenomatous Polyposis Coli (APC) tumour suppressor gene that leads to the activation of the Wnt signalling pathway, a key regulator of intestinal stemness. In fact, Apc loss is sufficient to induce multiple adenomas in the mouse intestine (Su et al, 1992; Cheung et al, 2010; Dow et al, 2015) . The Apc Min/ þ (multiple intestinal neoplasia) mouse model carries a single Apc mutation that is sufficient to induce the development of hundreds of benign adenomas in the small intestine of the mice by 4 to 6 months of age. Besides APC, mutations in KRAS, p53 and the transforming growth factor b (TGFb) pathways are known to be crucial for CRC progression (Fearon and Vogelstein, 1990; Drost et al, 2015) .
The current treatments for advanced CRC include surgery, and a combination of chemotherapies that are ineffective in a proportion of cases. Hence, it is of crucial importance to identify new therapeutic targets that can be exploited to improve CRC treatment and patient survival.
The nuclear factor-kB (NF-kB) is a key transcription factor that not only mediates innate and acquired immune responses but also regulates inflammation and carcinogenesis (Hayden and Ghosh, 2004; Hayden et al, 2006; Schulze-Luehrmann and Ghosh, 2006) . Activation of the pathway by different stimuli such as tumour necrosis factor-a (TNFa), bacterial and viral products or DNA damage induces the phosphorylation of the inhibitor of NF-kB (IkB) kinase (IKK) complex downstream of transforming growth factor b-activated kinase 1 (TAK1). This complex is composed by IKKa, IKKb and IKKg/NF-kB essential modulator (NEMO) (Ghosh and Karin, 2002 ) that phosphorylates IkB leading to its ubiquitination and subsequent degradation. Degradation of IkB allows the nuclear translocation of the NF-kB factor, mostly p65/p50 dimers, leading to the activation of the canonical pathway. The IKKa subunit also participates in the activation of the alternative NF-kB pathway that is independent of IKKb, NEMO and TAK1 (Vallabhapurapu and Karin, 2009 ). Specifically, factors inducing alternative NF-kB lead to the stabilisation of the NF-kB-inducing kinase (NIK) that in turn activates IKKa to phosphorylate p100. This cascade results in the proteolytic processing of p100 into p52 that will then translocate into the nucleus together with RelB to activate specific gene transcription.
Mostly related with its role in inflammation, several studies have demonstrated the association between NF-kB, IKKb and cancer (Karin and Greten, 2005) . In parallel, other reports identified NFkB-independent functions that are carried out by elements of the pathway, thus contributing to specific tumourigenic capabilities. Some examples are found in squamous cell carcinoma (SCC), where IKKa induces the release of SUMO-IkBa from the chromatin leading to HOX and IRX gene transcription (Mulero et al, 2013) . Also in SCC, nuclear IKKa regulates the levels of the metastasis suppressor gene Maspin (Toll et al, 2015) , similar to that found in prostate cancer cells (Luo et al, 2007) . In CRC, nuclear IKKa regulates the transcription of Notch target genes by phosphorylating the silencing mediator for retinoid and thyroid receptors (SMRT) and the nuclear receptor corepressor (N-CoR) (Fernández-Majada et al, 2007a, b) . Moreover, the presence of nuclear active IKKa correlates with cancer progression, and we recently identified a novel IKKa isoform with a predicted molecular weight of 45 kDa (p45-IKKa) that lacks several regulatory regions at the C-terminal end of the kinase (Margalef et al, 2012) . Active p45-IKKa localises in the nucleus of CRC cells and forms a complex with non-phosphorylated full-length IKKa and NEMO. Activation of this isoform involves the endosomal compartment and is induced by mutant BRAF V600E through the kinase TAK1 . Furthermore, a mouse model deficient in IKKa kinase activity displays reduced Wnt-driven intestinal tumour development associated with an enhanced recruitment of interferon-g (IFNg)-expressing M1-like myeloid cells (Göktuna et al, 2014) . These data demonstrate that IKKa is a key regulatory element of tumourigenesis that acts both in an NF-kB-dependent and -independent manner. In the latter, IKKa might directly regulate essential factors that participate in the oncogenic process. However, to date, there are no conclusive data unveiling the contribution of intestinal epithelial IKKa neither in normal intestinal homeostasis nor in the oncogenic transformation of the intestinal stem and progenitor cells.
We have here generated mice with deletion of IKKa in the intestinal epithelial cells that were crossed with a model of intestinal tumourigenesis driven by APC mutation. We found that intestinal epithelial IKKa is essential for tumour formation while dispensable for normal tissue homeostasis, both in in vivo and 3D in vitro cultures. Moreover, by RNA sequencing of wild-type (WT) and IKKa knockout (KO) tumouroids, we uncovered the molecular basis of IKKa addiction in transformed cells.
MATERIALS AND METHODS
Animals. For the generation of intestine-specific IKKa KO animals, the previously described Ikka FL mice (Gareus et al., 2007) were crossed with the Villin-Cre (from Jackson Laboratories, Bar Harbor, ME, USA) line, both in C57BL/6 background. Apc Min/ þ mice (from Jackson Laboratories) were from C57BL/6J background. All mice were genotyped by PCR and animals were kept under pathogen-free conditions. All the animal work was conducted according to the guidelines from Generalitat de Catalunya.
Immunohistochemistry. Formalin-fixed Swiss-roll intestinal samples were embedded in paraffin and sectioned at 4 mm. After dewaxing and rehydration, antigen retrieval was achieved using standard methods depending on the antibodies. Endogenous peroxidase activity was quenched by incubating the sections for 20 min with 1.5% H 2 O 2 . Primary antibodies Ki67 (Novocastra, Newcastle, UK, MM1), cleaved caspase 3 (Cell Signaling, Danvers, MA, USA, 9661) and b-catenin (Sigma-Aldrich, St Louis, MO, USA, C2206) were diluted in PBS containing 0.05% BSA and incubated overnight at 4 1C. Samples were then incubated with specific horseradish peroxidase (HRP)-labelled polymer (EnVision þ System, DAKO, Glostrup, Denmark), and staining was developed using DAB þ Substrate (Chromogen System, DAKO).
Intestinal adenoma isolation and tumouroid culture in Matrigel.
Intestinal crypts and adenomas used in the 3D cultures were isolated as previously described (Sato et al., 2011) . For organoid culture, we collected mouse small intestines, sliced them longitudinally and washed in cold PBS. Villi were removed by carefully scraping the surface, and the remaining tissue was cut into 3-5 mm sections. Samples were incubated twice in 2 mM EDTA for 30 min at 4 1C, filtered through a 100 mm pore diameter nylon and centrifuged at 110 g to obtain the crypt-enriched fraction. For tumouroid cultures, adenomas were isolated manually and incubated in 8 mM EDTA for 20 min at 4 1C. The remaining pellet was treated for 20 min at 37 1C in agitation with 0.4 mg ml Approximately 10 4 cells were seeded in 50 ml of Matrigel in 24-well plates. After polymerisation, 500 ml of complete medium ((DMEM/F12, Biological Industries, Kibbutz Beit-Haemek, Israel) with penicillin (100 U ml À 1 ) and streptomycin (100 mg ml À 1 ) (Biological Industries) supplemented with N2 and B27 (Invitrogen, Carlsbad, CA, USA) containing 140 nM ROCK inhibitor (Y27632, Sigma), 100 ng ml
Noggin (Peprotech, London, UK), 100 ng ml À 1 R-spondin (R&D Systems Minneapolis, MN, USA), 50 ng ml À 1 EGF (Sigma) and 20 ng ml À 1 basic FGF (Peprotech)) was added and cultures maintained at 37 1C in 5% CO 2 . Tumouroid measurement was performed using the standard parameters in Fiji-ImageJ (https://fiji.sc).
Tumouroid immunostaining. Tumouroids were seeded in Matrigel (Corning) onto a cover glass in a 24-well plate, and maintained in culture for 2 days. For whole-mount immunostaining, tumouroids were fixed with 4% paraformaldehyde for 20 min, permeabilised with 0.5% Triton X-100 (Pierce, Waltham, MA, USA) for 10 min and blocked in 2% BSA and 0.3% Triton X-100 for 1 h. Primary antibody (Ki67, Novocastra, MM1) was incubated overnight. After extensive washing, secondary antibody donkeyanti-mouse Alexa Fluor 488 (Molecular Probes, Eugene, OR, USA) was incubated for 2 h at room temperature. Slides were mounted in ProLong Diamond Antifade with DAPI (Thermofisher, Waltham, MA, USA).
Western blot analysis. Organoids and tumour spheroids were collected, centrifuged at 600 g for 5 min and lysed for 10 min at 4 1C in 100 ml of RIPA buffer supplemented with complete protease inhibitor cocktail (Roche, Basel, Switzerland). Lysates were then sonicated for 10 min and analysed by western blot using standard SDS-polyacrylamide gel electrophoresis (SDS-PAGE) techniques.
In brief, protein samples were boiled in Laemmli buffer, run in 8% polyacrylamide gels and transferred onto polyvinylidene difluoride membranes. The membranes were incubated overnight at 4 1C with the appropriate primary antibodies. After washing, membranes were incubated with specific secondary horseradish peroxidase-linked antibodies (DAKO) and visualised using the enhanced chemiluminescence reagent (Biological Industries).
Image analysis. The immunohistochemistry (IHC) of intestinal sections was visualised in an Olympus BX61 microscope (Olympus, Shinjuku, Tokyo, Japan), and images were taken using the cellSens Digital Imaging software (Olympus). Measurement of tumour spheroid length (diameter) was performed automatically with ImageJ Software (National Institutes of Health, Bethesda, MD, USA, https://imagej.nih.gov/ij/, 1997-2016) analysis. Quantification of IHC for Ki67 was done using Cell Profiler (Broad Institute, Cambridge, MA, USA). Immunofluorescence images of intestinal organoids and spheroids were taken in a Leica SP5 TCS upright microscope and the Leica Application Suite Advanced Fluorescence software (Wetzlar, Germany).
RNA-Seq experiment and analysis. Total RNA from three biological replicates per condition was extracted using RNeasy Micro Kit (Qiagen, Hilden, Germany). The RNA concentration and integrity were determined using Agilent Bioanalyser (Agilent Technologies, Santa Clara, CA, USA). Libraries were prepared and sequenced at the CRG Genomics unit (Barcelona, Spain) using standard protocols on an Illumina HiSeq2500 (San Diego, CA, USA). Heatmaps were generated using R studio (https://www.rstudio.com/) and GSEA, and statistical analysis was performed with publicly available software from the Broad Institute (http:// www.broadinstitute.org/gsea/index.jsp).
RESULTS AND DISCUSSION
IKKa deletion in the intestinal epithelium reduces tumour formation and proliferation. The IKK/NF-kB signalling pathway has emerged as a key regulator in multiple cancer types, including colon cancer (DiDonato et al, 2012) . However, NF-kB also exerts multiple essential physiological functions affecting cell survival that makes its general inhibition extremely toxic (Lam et al, 2005; Gasparian et al, 2009; Wright, 2010) .
As IKKa is not required for this general NF-kB function, and previous studies suggested its crucial role in intestinal tumourigenesis, we now studied the specific contribution of intestinal epithelial IKKa to neoplastic transformation. We used a mice strain carrying Cre recombinase under the control of Villin promoter (Villin-Cre). As Villin is specifically expressed in the epithelial cells of the small and large intestine (Madison et al, 2002) , crossing this strain with the one containing loxP site-flanked Ikka (Gareus et al, 2007) resulted in tissue-specific deletion of the kinase. We then crossed intestinal-specific Ikka KO mice with Apc Min/ þ mice to induce intestinal cell transformation in an IKKa-deficient background ( Figure 1A ). All different genotypes were born at the expected Mendelian ratios and showed no evident growth defects during the first 3 months of age, indicating that intestinal epithelial IKKa was dispensable for tissue homeostasis (data not shown). Further analysis of 3-month-old animals carrying the Apc Min/ þ allele demonstrated that IKKa deficiency imposed a significant decrease in the number of tumours arising in the small intestine when compared with the Ikka WT littermates or mice carrying one copy of the Ikka gene (Ikka þ / À ) ( Figures 1B and C) . Next, we studied the possibility that reduced proliferation of transformed cells might contribute to the observed phenotype. By IHC analysis, we found that Ikka WT adenomas showed a significantly higher percentage of proliferating Ki67-positive cells when compared with the Ikka KO adenomas (Figures 1D and E) . In contrast, we consistently failed to detect any histological difference or changes in the number of Ki67-positive cells in the nontransformed intestinal mucosa of IKKa WT, heterozygous or KO animals ( Figures 1F and  G) . Because active b-catenin plays a pivotal role in Apc-mutant tumour initiation and maintenance and it was previously identified as a target of IKKa (Albanese et al, 2003) , we aimed to determine whether nuclear b-catenin levels were reduced in the IKKa KO background. By IHC analysis we found that Ikka KO tumours show a significant decrease in the levels of nuclear b-catenin as compared with the Ikka control counterparts (Figures 1H and I) .
We next explored the possibility that decreased tumour number in the Apc Min/ þ Ikka KO mice were associated to increased apoptosis of the transformed cells. To do so we checked the levels of cleaved caspase 3. By IHC analysis of Ikka WT and KO Apc Min/ þ intestines, we observed very few cleaved caspase 3-positive areas within the tumours of both Ikka genotypes ( Figure 1J ). As a positive control, intestines of g-irradiated mice showed consistent cleaved caspase 3 staining ( Figure 1K ).
These results indicate that intestinal epithelial IKKa is essential for tumour initiation and tumour cell proliferation, likely through regulation of b-catenin signalling, but it is dispensable for maintaining normal homeostasis and proliferation of the intestine, a situation that is clinically exploitable. Whether differences on bcatenin activation were due to direct phosphorylation by IKKa need to be further investigated.
IKKa
À / À tumouroids show a decrease in size and proliferation. The in vivo experiments described above provide strong evidence of the role of IKKa in tumour formation in the APC Min/ þ mouse model. To further investigate the contribution of IKKa requirement in a pure intestinal epithelial tumour model, we used the ex vivo 3D culture system, in which single primary intestinal cells with tumour-initiating capability generate spheroidal structures (Sato et al, 2009 (Sato et al, , 2011 . We will here refer to these tumour spheroids as tumouroids. Consistent with our in vivo data, Ikka À / À ; Apc Min/ þ adenoma cells generated tumouroids that were significantly smaller in size than Ikka WT counterparts (Figure 2A ). This growth-deficient phenotype was much more pronounced in the initial cultures and attenuated after serial passaging of the tumouroid cultures. The significance of this result was confirmed by a careful quantification of sphere diameter ( Figure 2B ). Similar to that observed in the normal intestine, 3D organoid cultures, which were derived from nontransformed intestinal epithelial stem cells, showed no differences in their growing capacity when comparing Ikka þ / þ and Ikka À / À genotypes ( Figure 2C ). Immunofluorescence analysis of Ki67 expression demonstrated that Ikka À / À tumouroids were almost depleted from proliferating cells compared with Ikka þ / þ structures ( Figures 2D and E) . These results identify epithelial IKKa as an important contributor to intestinal tumour initiation activity ex vivo.
IKKa governs tumouroid growth by regulating stem cell proliferation and cell cycle-related gene programmes. We aimed to investigate the mechanisms underlying epithelial IKKa function in transformed cells by defining the transcriptional programmes that depend on IKKa in the Apc Min/ þ tumouroids. We performed RNA-seq from Apc Min/ þ Ikka WT or IKKa KO tumouroid cells. Data are accessible at the NCBI GEO database (Edgar et al, 2002) , accession GSE101415. Unsupervised cluster analysis demonstrated a clear co-segregation of WT and KO RNA samples ( Figure 3A) . Importantly, the transcriptional profile of Ikka KO tumouroids showed a significant decrease in the levels of a previously defined intestinal stem cell (ISC) signature (Muñoz et al, 2012) (Figure 3B (Wong et al, 2012) , among others. We further confirmed these results by qRT-PCR of several of these genes in a different set of tumouroids from both genotypes ( Figure 3C ). By Gene Set Enrichment Analysis (GSEA) we identified several pathways that were miss-regulated in the IKKadeficient adenoma cells compared with the WT. This applies to the apoptosis pathway that was significantly enriched in the absence of IKKa ( Figures 3D and F) , involving genes such as RIPK1, TRADD, FASLG, FAS and CASP8 among others. In contrast, IKKa-deficient adenomas showed a decrease in cell cycle-related genes For statistical analysis, ordinary one-way ANOVA or unpaired t-test was used and the P-values are indicated as ***Po0.001 and ****Po0.0001. ( Figure 3D ). IKKa deficiency also led to a decrease in the protumourigenic MYC signature, whereas it did not correlate with a general reduction in the canonical NF-kB signature (Figures 3E and F) , further suggesting that IKKa function in the intestinal adenoma stem cells is mainly NF-kB independent. These results are in agreement with our previous data indicating that IKKa regulates cell survival and proliferation in human CRC cells (Fernández-Majada et al, 2007a; Margalef et al, 2012 Margalef et al, , 2015 .
Collectively, our results demonstrate that intestinal epithelial IKKa exerts a cell-autonomous function in the intestinal adenoma stem cells affecting proliferation and stemness. Importantly, our data support the concept that IKKa is a plausible target for the development of new anticancer therapies from which CRC patients could benefit. Further investigation on the upstream and downstream effectors of cancer-associated IKKa activity will provide valuable information for the design of better and more selective therapies against human CRC. In fact, identification of the apoptotic pathway as a target of IKKa supports the notion that its inhibition could sensitise tumour cells to compounds that induce cell death such as chemotherapeutic agents.
